SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Carbotte RM, Denburg SD, Denburg JA. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 1986; 174: 35764.
  • 2
    Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol 1992; 19: 5627.
  • 3
    Ainiala H, Loukkola J, Peltola K, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496500.
  • 4
    Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002; 58: 121420.
  • 5
    Denburg SD, Denburg JA. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Lupus 2003; 12: 88390.
  • 6
    Hanly JG, Hong C, Smith S, Fisk JD. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 72834.
  • 7
    Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M. Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. J Clin Exp Neuropsychol 2002; 24: 52733.
  • 8
    Hanly JG, Cassel K, Fisk JD. Cognitive functions in systemic lupus erythematosus: results of a 5-year prospective study. Arthritis Rheum 1997; 40: 15423.
  • 9
    Kozora E, West SG, Kotzin BL, Julian L, Porter S, Bigler E. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1998; 41: 417.
  • 10
    Sabbadini MG, Manfredi AA, Bozzolo E, Ferrario L, Rugarli C, Scorza R, et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999; 8: 119.
  • 11
    Hachulla E, Michon-Pasturel U, Leys D, Pruvo JP, Queyrel V, Masy E, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998; 7: 12431.
  • 12
    Ishikawa O, Ohnishi K, Miyachi Y, Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging: relationship to anticardiolipin antibody. J Rheumatol 1994; 21: 8790.
  • 13
    Rovaris M, Pedroso C, Filippi M. Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome. Curr Rheumatol Rep 2001; 3: 3016.
  • 14
    Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, et al. Neuropsychiatric manifestation in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 98592.
  • 15
    McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunctions in patients with systemic lupus erythematosus. Neurology 2005; 64: 297303.
  • 16
    Boasso LE, Fischer AQ. Cerebral vasospasm in childhood migraine during the intermigrainous period. J Neuroimaging 2004; 14: 15861.
  • 17
    Sanchez del Rio M, Bakker D, Wu O, Agosti R, Mitsikostas DD, Ostergaard L, et al. Perfusion weighted imaging during migraine: spontaneous visual aura and headache. Cephalalgia 1999; 19: 7017.
  • 18
    Ferraccioli G, Di Poi E, Di Gregorio F, Giacomuzzi F, Guerra U. Changes in regional blood flow after a cold hand test in systemic lupus erythematosus patients with Raynaud's syndrome [letter]. Lancet 1999; 354: 21356.
  • 19
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 20
    ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599608.
  • 21
    Shortall E, Isenberg D, Newman SP. Factors associated with mood and mood disorders in SLE. Lupus 1995; 4: 2729.
  • 22
    Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patient with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 131120.
  • 23
    Wechsler D. Wechsler Memory Scale Forme I e II: manuale dall' adattamento italiano. Florence, Organizzazioni Speciali Firenze; 1974.
  • 24
    Wechsler D. Wechsler Adult Intelligence Scale-Revised: manuale dall' adattamento italiano. Florence, Organizzazioni Speciali Firenze; 1992.
  • 25
    Venturini R, Lombardo Radice M, Imperiali MG. Il “color-word test” o test di Stroop. Florence, Organizzazioni Speciali Firenze; 1983.
  • 26
    Spinnler H, Rognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987; 6 Suppl 8: 4850.
  • 27
    Glanz BI, Slonim D, Urowitz MB, Gladman DD, Gough J, MacKinnon A. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10: 2328.
  • 28
    Zigmond AS, Snaith RP. The anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 36170.
  • 29
    Apolone G, Mosconi P, Ware JE Jr. Questionario sullo stato di salute SF-36: manuale d'uso e guida all'interpretazione dei risultati. Guerini e Associati.
  • 30
    McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988; 31: 15966.
  • 31
    Molad Y, Sidi Y, Gornish M, Lerner M, Pinkhas J, Weinberger A. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. J Rheumatol 1992; 19: 55661.
  • 32
    Brady CB, Spiro A 3rd, Gaziano JM. Effects of age and hypertension status on cognition: the Veterans Affairs Normative Aging Study. Neuropsychology 2005; 19: 7707.
  • 33
    Raz N, Rodrigue KM, Acker JD. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav Neurosci 2003; 117: 116980.
  • 34
    Mortel KF, Meyer JS, Herod B, Thornby J. Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995; 6: 5562.
  • 35
    Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 2004; 43: 155560.
  • 36
    Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatol 2002; 41: 130812.
  • 37
    Waterloo K, Omdal R, Husby G, Mellgren SI. Neuropsychological function in systemic lupus erythematosus: a five-year longitudinal study. Rheumatology (Oxford) 2002; 41: 4115.
  • 38
    Waterloo K, Omdal R, Jacobsen EA, Klow NE, Husby G, Torbergsen T, et al. Cerebral computed tomography and electroencephalography compared with neuropsychological findings in systemic lupus erythematosus. J Neurol 1999; 246: 70611.
  • 39
    Ferbert A, Busse D, Thron A. Microinfarction in classic migraine? A study with magnetic resonance imaging findings. Stroke 1991; 22: 10104.
  • 40
    Hirashima Y, Kurimoto M, Tsukamoto E, Endo S, Takaku A. Antiphospholipid antibodies and cerebral vasospasm following subarachnoid hemorrage. Acta Neurochir (Wien) 1995; 135: 1917.
  • 41
    Ainiala H, Dastidar P, Loukkola J, Lehtimaki T, Korpela M, Hietahariu A. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005; 34: 37682.
  • 42
    Denes G, Pizzamiglio L. Neuropsychology handbook. 2nd ed. Bologna (Italy): Zanichelli; 1996; p. 11731406. In Italian.